Boehringer Ingelheim joined the Veeva AI Early Adopter Program and spent four months piloting Quick Check Agent and Content Agent in PromoMats for medical, legal, and regulatory (MLR) review. Veeva's story shares lessons but no quantified outcomes.
Reported outcomes
No quantified outcome has been published in the sources we found. We will update this case when one appears.
Outcomes are reported exactly as stated by the source; we have not independently audited them.
How it works
- Quick Check Agent pre-screens promotional content before MLR submission.
- Content Agent assists with content work inside PromoMats.
- Piloted with Veeva Business Consulting within live processes.
Risks & compliance
- Promotional compliance; AI checks do not replace MLR reviewers
- Vendor-published
Healthcare cases cover operational and commercial workflows. Nothing here is medical advice or a claim about a device's or drug's efficacy.
Tools mentioned & how to build it
Disclosure: Some links may earn us a commission; it never affects grades. Tools are listed by fit to this case, never by payment.
Tools mentioned
- Veeva AI Agents (Veeva Systems)
Life-sciences CRM and content (PromoMats) with built-in AI agents.
Build a version yourself
- Make
Visual no-code automation with AI agents; good for intake, routing and follow-up flows. - HubSpot (Breeze agents)
SMB-friendly CRM with Breeze AI agents for prospecting and support. - Jasper
AI marketing content with brand controls.
Sources
“Over four months, Boehringer partnered closely with Veeva Business Consulting to pilot Veeva AI capabilities — including Quick Check Agent and Content Agent”Boehringer Ingelheim Is a Veeva AI Early Adopter
Grade rationale: Named organization; no specific quantified outcome in the sources. Automated check on Oct 17, 2026: 1/1 quotes and 0/0 outcome claims matched the source. Compiled by the Agent Casefile research desk (AI-assisted; see methodology). Spot an error? Request a correction.
